57 results
Page 3 of 3
6-K
EX-99.1
dndb1u5yaeso
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
tmhuvf
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
m3purnhd
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
9iibt4svp0dp
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
yyf4ohg
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.12.5
ypuscpescjb
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.6
wm0myakcj7bq
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
3k6umr
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
u4vdy6gr
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
8kg0kl31pzy iowyi
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
v5mwi9w cf1xd
29 May 20
Draft registration statement (amended)
12:00am
DRSLTR
csx61e384uvsslqi aw1
28 May 20
Correspondence regarding draft registration statement
12:00am
DRS/A
EX-10.6
zmujn 7u3w0xhf
11 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
2zrdg6a2j4bp7jb2
11 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
ic27b8gy2w8l9qwl83s
11 May 20
Draft registration statement (amended)
12:00am
UPLOAD
jieeldu8tu6 0e1ur2yq
19 Mar 20
Letter from SEC
12:00am
DRS
k9ahoi5h3y 16en
19 Feb 20
Draft registration statement
12:00am